Drugs Made In America Acquisition Corp. (DMAA)

NASDAQ: DMAA · Real-Time Price · USD
10.46
-0.02 (-0.19%)
At close: Feb 27, 2026, 4:00 PM EST
10.46
-0.01 (-0.05%)
After-hours: Feb 27, 2026, 4:00 PM EST
4.91%
Market Cap 350.59M
Revenue (ttm) n/a
Net Income (ttm) 5.45M
Shares Out 33.52M
EPS (ttm) 0.21
PE Ratio 48.71
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 206
Open 10.46
Previous Close 10.48
Day's Range 10.46 - 10.46
52-Week Range 9.96 - 10.48
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About DMAA

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Jan 28, 2025
Country United States
Stock Exchange NASDAQ
Ticker Symbol DMAA
Full Company Profile

News

There is no news available yet.